{"id":217072,"date":"2023-04-07T04:48:03","date_gmt":"2023-04-07T04:48:03","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=217072"},"modified":"2023-04-07T04:48:03","modified_gmt":"2023-04-07T04:48:03","slug":"homologous-titre","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/homologous-titre\/","title":{"rendered":"Homologous titre"},"content":{"rendered":"<p>The dilution endpoint refers to the maximum degree of dilution that can be achieved for an antiserum without compromising its ability to bind to the corresponding antigen that was utilized in its creation. This critical point is typically determined by performing an antigen-antibody assay, in which the antiserum is tested against the same antigen that was used in its production. The dilution endpoint is established when the antiserum can no longer bind to the antigen in a detectable manner.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The dilution endpoint refers to the maximum degree of dilution that can be achieved for an antiserum without compromising its ability to bind to the corresponding antigen that was utilized in its creation. This critical point is typically determined by performing an antigen-antibody assay, in which the antiserum is tested against the same antigen that [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"class_list":["post-217072","post","type-post","status-publish","format-standard","hentry","category-h"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Homologous titre - Definition of Homologous titre<\/title>\n<meta name=\"description\" content=\"The dilution endpoint refers to the maximum degree of dilution that can be achieved for an antiserum without compromising its ability to bind to the corresponding antigen that was utilized in its creation. This critical point is typically determined by performing an antigen-antibody assay, in which the antiserum is tested against the same antigen that was used in its production. The dilution endpoint is established when the antiserum can no longer bind to the antigen in a detectable manner.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/homologous-titre\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Homologous titre - Definition of Homologous titre\" \/>\n<meta property=\"og:description\" content=\"The dilution endpoint refers to the maximum degree of dilution that can be achieved for an antiserum without compromising its ability to bind to the corresponding antigen that was utilized in its creation. This critical point is typically determined by performing an antigen-antibody assay, in which the antiserum is tested against the same antigen that was used in its production. The dilution endpoint is established when the antiserum can no longer bind to the antigen in a detectable manner.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/homologous-titre\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-07T04:48:03+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/homologous-titre\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/homologous-titre\/\",\"name\":\"Homologous titre - Definition of Homologous titre\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2023-04-07T04:48:03+00:00\",\"dateModified\":\"2023-04-07T04:48:03+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"The dilution endpoint refers to the maximum degree of dilution that can be achieved for an antiserum without compromising its ability to bind to the corresponding antigen that was utilized in its creation. This critical point is typically determined by performing an antigen-antibody assay, in which the antiserum is tested against the same antigen that was used in its production. The dilution endpoint is established when the antiserum can no longer bind to the antigen in a detectable manner.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/homologous-titre\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/homologous-titre\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/homologous-titre\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Homologous titre\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Homologous titre - Definition of Homologous titre","description":"The dilution endpoint refers to the maximum degree of dilution that can be achieved for an antiserum without compromising its ability to bind to the corresponding antigen that was utilized in its creation. This critical point is typically determined by performing an antigen-antibody assay, in which the antiserum is tested against the same antigen that was used in its production. The dilution endpoint is established when the antiserum can no longer bind to the antigen in a detectable manner.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/homologous-titre\/","og_locale":"en_US","og_type":"article","og_title":"Homologous titre - Definition of Homologous titre","og_description":"The dilution endpoint refers to the maximum degree of dilution that can be achieved for an antiserum without compromising its ability to bind to the corresponding antigen that was utilized in its creation. This critical point is typically determined by performing an antigen-antibody assay, in which the antiserum is tested against the same antigen that was used in its production. The dilution endpoint is established when the antiserum can no longer bind to the antigen in a detectable manner.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/homologous-titre\/","og_site_name":"Glossary","article_published_time":"2023-04-07T04:48:03+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/homologous-titre\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/homologous-titre\/","name":"Homologous titre - Definition of Homologous titre","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2023-04-07T04:48:03+00:00","dateModified":"2023-04-07T04:48:03+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"The dilution endpoint refers to the maximum degree of dilution that can be achieved for an antiserum without compromising its ability to bind to the corresponding antigen that was utilized in its creation. This critical point is typically determined by performing an antigen-antibody assay, in which the antiserum is tested against the same antigen that was used in its production. The dilution endpoint is established when the antiserum can no longer bind to the antigen in a detectable manner.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/homologous-titre\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/homologous-titre\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/homologous-titre\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Homologous titre"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/217072","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=217072"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/217072\/revisions"}],"predecessor-version":[{"id":217073,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/217072\/revisions\/217073"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=217072"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=217072"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=217072"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}